Clinical Trial Update: Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sorafenib tosylate after liver transplant for hepatocellular carcinoma and related liver cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Drugs mentioned

• Sorafenib tosylate (sorafenib tosylate)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer | Phase 2 | Status: COMPLETED